Literature DB >> 9427687

Cells from ERCC1-deficient mice show increased genome instability and a reduced frequency of S-phase-dependent illegitimate chromosome exchange but a normal frequency of homologous recombination.

D W Melton1, A M Ketchen, F Núñez, S Bonatti-Abbondandolo, A Abbondandolo, S Squires, R T Johnson.   

Abstract

The ERCC1 protein is essential for nucleotide excision repair in mammalian cells and is also believed to be involved in mitotic recombination. ERCC1-deficient mice, with their extreme runting and polyploid hepatocyte nuclei, have a phenotype that is more reminiscent of a cell cycle arrest/premature ageing disorder than the classic DNA repair deficiency disease, xeroderma pigmentosum. To understand the role of ERCC1 and the link between ERCC1-deficiency and cell cycle arrest, we have studied primary and immortalised embryonic fibroblast cultures from ERCC1-deficient mice and a Chinese hamster ovary ERCC1 mutant cell line. Mutant cells from both species showed the expected nucleotide excision repair deficiency, but the mouse mutant was only moderately sensitive to mitomycin C, indicating that ERCC1 is not essential for the recombination-mediated repair of interstrand cross links in the mouse. Mutant cells from both species had a high mutation frequency and the level of genomic instability was elevated in ERCC1-deficient mouse cells, both in vivo and in vitro. There was no evidence for an homologous recombination deficit in ERCC1 mutant cells from either species. However, the frequency of S-phase-dependent illegitimate chromatid exchange, induced by ultra violet light, was dramatically reduced in both mutants. In rodent cells the G1 arrest induced by ultra violet light is less extensive than in human cells, with the result that replication proceeds on an incompletely repaired template. Illegitimate recombination, resulting in a high frequency of chromatid exchange, is a response adopted by rodent cells to prevent the accumulation of DNA double strand breaks adjacent to unrepaired lesion sites on replicating DNA and allow replication to proceed. Our results indicate an additional role for ERCC1 in this process and we propose the following model to explain the growth arrest and early senescence seen in ERCC1-deficient mice. In the absence of ERCC1, spontaneously occurring DNA lesions accumulate and the failure of the illegitimate recombination process leads to the accumulation of double strand breaks following replication. This triggers the p53 response and the G2 cell cycle arrest, mediated by increased expression of the cyclin-dependent kinase inhibitor p21(cip1/waf1). The increased levels of unrepaired lesions and double strand breaks lead to an increased mutation frequency and genome instability.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9427687     DOI: 10.1242/jcs.111.3.395

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  24 in total

1.  The structure-specific endonuclease Ercc1-Xpf is required for targeted gene replacement in embryonic stem cells.

Authors:  L J Niedernhofer; J Essers; G Weeda; B Beverloo; J de Wit; M Muijtjens; H Odijk; J H Hoeijmakers; R Kanaar
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

2.  Influence of homologous recombinational repair on cell survival and chromosomal aberration induction during the cell cycle in gamma-irradiated CHO cells.

Authors:  Paul F Wilson; John M Hinz; Salustra S Urbin; Peter B Nham; Larry H Thompson
Journal:  DNA Repair (Amst)       Date:  2010-07-01

3.  Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.

Authors:  Fuli Zhao; Yuhong Shang; Chen Zeng; Dongdong Gao; Ke Li
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

4.  ERCC1 function in nuclear excision and interstrand crosslink repair pathways is mediated exclusively by the ERCC1-202 isoform.

Authors:  Luc Friboulet; Sophie Postel-Vinay; Tony Sourisseau; Julien Adam; Annabelle Stoclin; Florence Ponsonnailles; Nicolas Dorvault; Frédéric Commo; Patrick Saulnier; Sophie Salome-Desmoulez; Géraldine Pottier; Fabrice André; Guido Kroemer; Jean-Charles Soria; Ken André Olaussen
Journal:  Cell Cycle       Date:  2013-09-09       Impact factor: 4.534

5.  Correction of liver dysfunction in DNA repair-deficient mice with an ERCC1 transgene.

Authors:  J Selfridge; K T Hsia; N J Redhead; D W Melton
Journal:  Nucleic Acids Res       Date:  2001-11-15       Impact factor: 16.971

6.  Association of single-nucleotide polymorphisms in ERCC1 and ERCC2 with glioma risk.

Authors:  Lei Hui; Shuangzhu Yue; Guojun Gao; Haigang Chang; Xiangsheng Li
Journal:  Tumour Biol       Date:  2014-05-01

7.  PARP inhibition enhances tumor cell-intrinsic immunity in ERCC1-deficient non-small cell lung cancer.

Authors:  Roman M Chabanon; Gareth Muirhead; Dragomir B Krastev; Julien Adam; Daphné Morel; Marlène Garrido; Andrew Lamb; Clémence Hénon; Nicolas Dorvault; Mathieu Rouanne; Rebecca Marlow; Ilirjana Bajrami; Marta Llorca Cardeñosa; Asha Konde; Benjamin Besse; Alan Ashworth; Stephen J Pettitt; Syed Haider; Aurélien Marabelle; Andrew Nj Tutt; Jean-Charles Soria; Christopher J Lord; Sophie Postel-Vinay
Journal:  J Clin Invest       Date:  2019-02-11       Impact factor: 14.808

Review 8.  Chlamydomonas reinhardtii: a convenient model system for the study of DNA repair in photoautotrophic eukaryotes.

Authors:  Daniel Vlcek; Andrea Sevcovicová; Barbara Sviezená; Eliska Gálová; Eva Miadoková
Journal:  Curr Genet       Date:  2007-11-09       Impact factor: 3.886

9.  Association of NER pathway gene polymorphisms with susceptibility to laryngeal cancer in a Chinese population.

Authors:  Yanan Sun; Lijun Tan; Huijun Li; Xiaowei Qin; Jiangtao Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 10.  Fanconi anemia proteins, DNA interstrand crosslink repair pathways, and cancer therapy.

Authors:  Paul R Andreassen; Keqin Ren
Journal:  Curr Cancer Drug Targets       Date:  2009-02       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.